Kelly Klega

524 citations
16 papers · 232 indexed · h-index 7
Topics
Sarcoma Diagnosis and Treatment (13 papers)Cancer Genomics and Diagnostics (13 papers)Neuroblastoma Research and Treatments (3 papers)

In The Last Decade

Kelly Klega

16 papers receiving 231 citations

Peers

Kelly Klega
Comparison fields: 5 of 31
  • Pulmonary and Respiratory Medicine 158
  • Cancer Research 140
  • Molecular Biology 91
  • Oncology 84
  • Pathology and Forensic Medicine 44
Replace Abigail Ward with:
Abigail Ward United States
Francesca Rastelli Italy
Ashley Woodson United States
Nabahet Ameur France
Donna C. Ferguson United States
Kaisa Sunela Finland
Taro Isobe Japan
Anja Lisa Riediger Germany
Eva Koscielniak Germany
Sadhanna Badeloe Netherlands
Kelly Klega relative to Abigail Ward United States Abigail Ward's profile →
Citations per field
00.5×3.6×
Abigail Ward · 1×
Citations per year

Countries citing papers authored by Kelly Klega

Since Specialization
Citations

This map shows the geographic impact of Kelly Klega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Klega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Klega more than expected).

Fields of papers citing papers by Kelly Klega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Klega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Klega. The network helps show where Kelly Klega may publish in the future.

Co-authorship network of co-authors of Kelly Klega

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Klega. A scholar is included among the top collaborators of Kelly Klega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Klega. Kelly Klega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 21
5 3
6 16
7 15
8 1
9 12
10 6
11 18
12 4
13 1
14 46
15 84
16 2

About Kelly Klega

Kelly Klega is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 16 papers that have together received 232 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (13 papers), Cancer Genomics and Diagnostics (13 papers) and Neuroblastoma Research and Treatments (3 papers). The work is most often cited by research in Cancer Research (140 citations), Pulmonary and Respiratory Medicine (158 citations) and Oncology (84 citations). Kelly Klega has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Brian D. Crompton, Aaron R. Thorner, Anwesha Nag, Gavin Ha, Steven G. DuBois, Elizabeth A. Mullen, Alma Imamović, Catherine Clinton, Abigail Ward and Eliezer M. Van Allen. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026